Robert Cowles

Dr. Robert Cowles


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2021 in Cells
Verified
Journal Article
Open access
PDF file
PSPooja S. Salvi
Pooja S. Salvi
RCRobert Cowles
Robert Cowles
The microbial metabolite butyrate serves as a link between the intestinal microbiome and epithelium. The monocarboxylate transporters MCT1 and SMCT1 are the predominant means of butyrate transport from the intestinal lumen to epithelial cytoplasm, where the molecule undergoes rapid β-oxidation to generate cellular fuel. However, not all epithelial cells metabolize butyrate equally. Undifferentiated colonocytes, including neoplastic cells and intestinal stem cells at the epithelial crypt base preferentially utilize glucose over butyrate for cellular fuel. This divergent metabolic conditioning is central to the phenomenon known as “butyrate paradox”, in which butyrate induces contradictory effects on epithelial proliferation in undifferentiated and differentiated colonocytes. There is evidence that accumulation of butyrate in epithelial cells results in histone modification and altered transcriptional activation that halts cell cycle progression. This manifests in the apparent protective effect of butyrate against colonic neoplasia. A corollary to this process is butyrate-induced inhibition of intestinal stem cells. Yet, emerging research has illustrated that the evolution of the crypt, along with butyrate-producing bacteria in the intestine, serve to protect crypt base stem cells from butyrate’s anti-proliferative effects. Butyrate also regulates epithelial inflammation and tolerance to antigens, through production of anti-inflammatory cytokines and induction of tolerogenic dendritic cells. The role of butyrate in the pathogenesis and treatment of intestinal neoplasia, inflammatory bowel disease and malabsorptive states is evolving, and holds promise for the potential translation of butyrate’s cellular function into clinical therapies.

1 January 2021 in Cellular and Molecular Gastroenterology and Hepatology
Verified
Journal Article
Open access
PSPooja A. Shah
Pooja A. Shah
CPChristine J. Park
Christine J. Park
MSMatthew P. Shaughnessy
Matthew P. Shaughnessy
RCRobert Cowles
Robert Cowles
Serotonin signaling is ubiquitous in the gastrointestinal (GI) system, where it acts as a neurotransmitter in the enteric nervous system (ENS) and influences intestinal motility and inflammation. Since its discovery, serotonin has been linked to cellular proliferation in several types of tissues, including vascular smooth muscle, neurons, and hepatocytes. Activation of serotonin receptors (5-HTRs) on distinct cell types has been shown to induce well-known intracellular proliferation pathways. In the GI tract, potentiation of serotonin signaling results in enhanced intestinal epithelial proliferation, and decreased injury from intestinal inflammation. Furthermore, activation of 5-HTR4 on enteric neurons leads to neurogenesis and neuroprotection in the setting of intestinal injury. It is not surprising that the mitogenic properties of serotonin are pronounced within the GI tract, where enterochromaffin cells in the intestinal epithelium produce 90% of the body's serotonin; however, these proliferative effects are attributed to increased serotonin signaling within the ENS compartment as opposed to the intestinal mucosa, which are functionally and chemically separate by virtue of the distinct TPH enzyme isoforms involved in serotonin synthesis. The exact mechanism by which serotonergic neurons in the ENS lead to intestinal proliferation are not known, but the activation of muscarinic receptors on intestinal crypt cells indicate that cholinergic signaling is essential to this signaling pathway. Further understanding of serotonin's role in mucosal and enteric nervous system mitogenesis may aid in harnessing serotonin signaling for therapeutic benefit in many GI diseases, including inflammatory bowel disease, malabsorptive conditions, and cancer.

18 December 2015 in World Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
EMEleanor Dorothy Muise
Eleanor Dorothy Muise
RCRobert Cowles
Robert Cowles

1 January 2014 in World Journal of Radiology
Verified
Journal Article
Open access
JTJohn J Tackett
John J Tackett
EMEleanor D Muise
Eleanor D Muise
RCRobert Cowles
Robert Cowles
Malrotation: Current strategies navigating the radiologic diagnosis of a surgical emergency

1 November 2021 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
MSMatthew P. Shaughnessy
Matthew P. Shaughnessy
NMNathan L. Maassel
Nathan L. Maassel
NYNicholas Yung
Nicholas Yung
DSDaniel G. Solomon
Daniel G. Solomon
RCRobert Cowles
Robert Cowles

1 March 2016 in Journal of Surgical Research
Verified
Journal Article
Closed access
EMEleanor D. Muise
Eleanor D. Muise
SHSteven Hardee
Steven Hardee
RMRaffaella A. Morotti
Raffaella A. Morotti
RCRobert Cowles
Robert Cowles